A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema (NCT05224102)
A Phase IV, Multicenter, Open-Label, Single-Arm Study to Investigate Faricimab (RO6867461) Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
🩺 Plain-English Summary (8th-Grade Level)
This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, Hispanic/Latino American, or Native American/Alaska Native/Native Hawaiian or other Pacific Islander; in addition, a cohort of Asian Indian participants will be enrolled in India.
Who can join: Review the eligibility criteria below.
Location: Barnet Dulaney Perkins Eye Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (43 Sites)
Showing the first 25 of 43 sites.
- Barnet Dulaney Perkins Eye Center — Phoenix, Arizona
- Win Retina — Arcadia, California
- Retinal Diagnostic Center — Campbell, California
- Retina Consultants of Orange County — Fullerton, California
- Kaiser Permanente Southern California — Los Angeles, California
- Retinal Consultants Medical Group — Sacramento, California
- Southwest Retina Consultants — Durango, Colorado
- Emerson Clinical Research Institute LLC — Washington D.C., District of Columbia
- Blue Ocean Clinical Research — Clearwater, Florida
- Retina Macula Specialists of Miami - LeJeune Road Office — Miami, Florida
- Florida Retina Institute — Orlando, Florida
- Fort Lauderdale Eye Institute — Plantation, Florida
- University Retina and Macula Associates, PC — Oak Forest, Illinois
- Wilmer Eye Institute Johns Hopkins University — Baltimore, Maryland
- Md Medical Research — Oxon Hill, Maryland
- Retina Associates of Michigan — Grand Blanc, Michigan
- Retina Consultants of Nevada — Henderson, Nevada
- Sierra Eye Associates — Reno, Nevada
- The Retina Center of New Jersey — Bloomfield, New Jersey
- NJ Retina - Teaneck — Teaneck, New Jersey
- Piedmont Retina Specialists — Winston-Salem, North Carolina
- Retina Associates of Cleveland, INC — Beachwood, Ohio
- Scheie Eye Institute — Philadelphia, Pennsylvania
- Wills Eye Hospital — Philadelphia, Pennsylvania
- Black Hills Eye Institute — Rapid City, South Dakota
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetic Macular Edema
- Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT) — Beverly Hills, California
- 4D-150 in Patients With Diabetic Macular Edema — Hagerstown, Maryland
- Mean Visual Acuity Changes Following Five Injections of Aflibercept — Hamilton, Ontario
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) — Mesa, Arizona
- A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME — Mesa, Arizona
Explore by condition: All Diabetic Macular Edema clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.